Drugs / PF-07257876
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04881045 | Aug 2021 → Oct 2023 | head and neck squamous cell carcinoma, non-small cell lung carcinoma, ovarian cancer | Pfizer | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PF-07257876 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04881045 ↗ |